Mirae Asset Global Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Buy |
3,619
+505
| +16% | +$14.5K | ﹤0.01% | 1132 |
|
|
2025
Q1 | $108K | Buy |
3,114
+24
| +0.8% | +$834 | ﹤0.01% | 1117 |
|
|
2024
Q4 | $160K | Buy |
3,090
+195
| +7% | +$10.1K | ﹤0.01% | 1079 |
|
|
2024
Q3 | $147K | Buy |
2,895
+541
| +23% | +$27.5K | ﹤0.01% | 1138 |
|
|
2024
Q2 | $102K | Sell |
2,354
-30,171
| -93% | -$1.31M | ﹤0.01% | 1139 |
|
|
2024
Q1 | $769K | Sell |
32,525
-6,693
| -17% | -$158K | ﹤0.01% | 1678 |
|
|
2023
Q4 | $1.4M | Buy |
39,218
+2,343
| +6% | +$83.4K | ﹤0.01% | 1441 |
|
|
2023
Q3 | $1.1M | Buy |
36,875
+7,021
| +24% | +$209K | ﹤0.01% | 1479 |
|
|
2023
Q2 | $537K | Sell |
29,854
-256
| -0.9% | -$4.61K | ﹤0.01% | 1915 |
|
|
2023
Q1 | $484K | Buy |
30,110
+4,841
| +19% | +$77.7K | ﹤0.01% | 1945 |
|
|
2022
Q4 | $462K | Buy |
25,269
+1,833
| +8% | +$33.5K | ﹤0.01% | 1933 |
|
|
2022
Q3 | $460K | Buy |
23,436
+8,167
| +53% | +$160K | ﹤0.01% | 1917 |
|
|
2022
Q2 | $284K | Buy |
+15,269
| New | +$284K | ﹤0.01% | 2015 |
|